From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments.
- DOI
- 10.3390/children13081121
- Published
- 2026 Aug 21
- Container
- Children (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/children13081121,
title = {From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments.},
author = {Șerban RC and Mitut-Veliscu A and Dumitra A and Marica L and Popescu C and Costache A and Teona Ș and Riza AL and Dirnu R and Varut RM and Streață I},
year = {2026},
journal = {Children (Basel, Switzerland)},
doi = {10.3390/children13081121},
url = {https://doi.org/10.3390/children13081121}
}RIS
TY - JOUR TI - From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments. AU - Șerban RC AU - Mitut-Veliscu A AU - Dumitra A AU - Marica L AU - Popescu C AU - Costache A AU - Teona Ș AU - Riza AL AU - Dirnu R AU - Varut RM AU - Streață I PY - 2026 JO - Children (Basel, Switzerland) DO - 10.3390/children13081121 UR - https://doi.org/10.3390/children13081121 ER -
APA
RC, Ș., A, M., A, D., L, M., C, P., A, C., Ș, T., AL, R., R, D., RM, V., & I, S. (2026). From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments.. Children (Basel, Switzerland). https://doi.org/10.3390/children13081121
Source records
- pubmed · retrieved 2026-09-27T15:32:21.017Z